Inhaled siRNA therapy targeting RAGE for pulmonary inflammation: a first-in-human randomized trial.

O'Carroll M, Kasahara D, Huetsch J, Reed T, Perkins TN, Zhou R, Moser L, Tomasini-Johansson B, Ta A, Oury TD, Pei T, Hamilton J, Bush EW, Leeper NJ, Salathe M, RAGE study consortium

Open source

DOI
10.1038/s41591-026-04607-z
Published
2026 Sep
Container
Nature medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41591-026-04607-z,
  title = {Inhaled siRNA therapy targeting RAGE for pulmonary inflammation: a first-in-human randomized trial.},
  author = {O'Carroll M and Kasahara D and Huetsch J and Reed T and Perkins TN and Zhou R and Moser L and Tomasini-Johansson B and Ta A and Oury TD and Pei T and Hamilton J and Bush EW and Leeper NJ and Salathe M and RAGE study consortium},
  year = {2026},
  journal = {Nature medicine},
  doi = {10.1038/s41591-026-04607-z},
  url = {https://doi.org/10.1038/s41591-026-04607-z}
}

RIS

TY  - JOUR
TI  - Inhaled siRNA therapy targeting RAGE for pulmonary inflammation: a first-in-human randomized trial.
AU  - O'Carroll M
AU  - Kasahara D
AU  - Huetsch J
AU  - Reed T
AU  - Perkins TN
AU  - Zhou R
AU  - Moser L
AU  - Tomasini-Johansson B
AU  - Ta A
AU  - Oury TD
AU  - Pei T
AU  - Hamilton J
AU  - Bush EW
AU  - Leeper NJ
AU  - Salathe M
AU  - RAGE study consortium
PY  - 2026
JO  - Nature medicine
DO  - 10.1038/s41591-026-04607-z
UR  - https://doi.org/10.1038/s41591-026-04607-z
ER  - 

APA

M, O., D, K., J, H., T, R., TN, P., R, Z., L, M., B, T., A, T., TD, O., T, P., J, H., EW, B., NJ, L., M, S., & consortium, R. S. (2026). Inhaled siRNA therapy targeting RAGE for pulmonary inflammation: a first-in-human randomized trial.. Nature medicine. https://doi.org/10.1038/s41591-026-04607-z

Source records